Trecondyv (treosulfan)

pCPA File Number: 22608

Negotiation Status:

Concluded with an LOI

Indication(s):

As part of conditioning treatment prior to allogeneic hematopoietic stem cell transplantation (alloHSCT) in adult patients with AML or MDS at increased risk for standard conditioning therapies (In combination with fludarabine)

Sponsor/Manufacturer:

Medexus Pharmaceuticals, Inc.

CDA-AMC Project Number:

PC0324-000

pCPA Engagement Letter Issued:

2024-07-30

Negotiation Process Concluded:

2024-11-04